Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-03-08 Sale | 2022-03-09 4:50 pm | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 2,339 | $70.1 | $163,964 | 62,462 (Direct) | View |
2022-03-03 Sale | 2022-03-07 6:28 pm | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 3,067 | $71.87 | $220,414 | 70,907 (Direct) | View |
2021-01-15 Sale | 2021-01-19 5:00 pm | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 63,814 | $172.48 | $11,006,647 | 59,660 (Direct) | View |
2020-02-28 Sale | 2020-03-02 5:11 pm | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 2,643 | $72.22 | $190,864 | 75,587 (Direct) | View |
2020-02-25 Sale | 2020-02-26 5:14 pm | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 8,482 | $81.16 | $688,365 | 67,119 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-03-03 Option Award | 2022-03-07 6:28 pm | 2023-03-01 2032-02-29 | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 6,106 | $80.59 | 70,907 (Direct) | View |
2021-07-06 Option Award | 2021-07-08 5:26 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 154 | $137.12 | 67,868 (Direct) | View |
2021-03-02 Option Award | 2021-03-04 5:44 pm | N/A 2031-03-01 | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 29,346 | $0 | 92,206 (Direct) | View |
2021-02-27 Exercise | 2021-03-02 4:15 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 5,555 | $149.1 | 65,215 (Direct) | View |
2021-02-27 Exercise | 2021-03-02 4:15 pm | 2021-02-27 N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 5,555 | $0 | 65,215 (Direct) | View |
2021-01-15 Exercise | 2021-01-19 5:00 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 36,396 | $14.37 | 59,660 (Direct) | View |
2021-01-15 Exercise | 2021-01-19 5:00 pm | N/A 2025-02-23 | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 36,396 | $0 | 59,660 (Direct) | View |
2020-07-07 Option Award | 2020-07-08 4:24 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 325 | $50.41 | 87,078 (Direct) | View |
2020-03-03 Option Award | 2020-03-05 6:50 pm | N/A 2030-03-02 | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 56,278 | $0 | 126,310 (Direct) | View |
2020-02-27 Exercise | 2020-03-02 5:11 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 5,556 | $79.45 | 75,587 (Direct) | View |
2020-02-27 Exercise | 2020-03-02 5:11 pm | 2019-02-27 N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 5,556 | $0 | 75,587 (Direct) | View |
2020-02-24 Exercise | 2020-02-26 5:14 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 21,666 | $88.26 | 67,119 (Direct) | View |
2020-02-24 Exercise | 2020-02-26 5:14 pm | 2020-02-22 N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 21,666 | $0 | 67,119 (Direct) | View |
2020-01-08 Option Award | 2020-01-13 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 35 | $52.58 | 53,935 (Direct) | View |